Even Lower Doses Of SGLT2 Inhibitors Effective For Renoprotection In Type 2 Diabetes Dr. Kamal Kant Kohli23 Jun 2023 11:15 AM ISTA comprehensive study published in the journal Acta Diabetologica aimed at comparing the renoprotective effects of different dosages of sodium-glucose...
SGLT2 inhibitors, metformin tied to prolonged survival in type 2 diabetes compared to other drugs Medha Baranwal17 Jun 2023 11:15 AM ISTSwitzerland: A recent study has shown that current first-line antidiabetic medication, SGLT2 inhibitors, or metformin, raises the survival probability...
SGLT2 inhibitors used less frequently in HFrEF patients despite potential CV benefits: JAMA Medha Baranwal24 May 2023 10:30 AM ISTUSA: A recent study published in JAMA Cardiology found low rates of SGLT2 inhibitors for HFrEF (heart failure with reduced ejection fraction) in the...
Which new diabetes drugs pose risk of digestive diseases? Medha Baranwal11 April 2023 11:00 AM ISTChina: Glucagon-like peptide 1 receptor agonists (GLP1RAs) should not be given to patients at high risk of certain digestive diseases, whereas...
SGLT2 inhibitors improve FIB-4 index better than pioglitazone in MAFLD patients Aditi20 March 2023 10:30 AM ISTJapan: A study entitled "Effects of sodium-glucose cotransporter two inhibitors and pioglitazone on FIB-4 index in metabolic associated fatty liver...
Canagliflozin use tied to reduced proteinuria in diabetes patients with HF Dr Kartikeya Kohli7 March 2023 9:00 AM ISTJapan: Proteinuria regression with canagliflozin treatment in patients with T2DM (type 2 diabetes mellitus) and chronic heart failure (CHF) is...
SGLT2 inhibitors with conventional diuretics lower all-cause mortality in HF patients Jacinthlyn Sylvia11 Jan 2023 11:15 AM ISTA systematic review of nine randomized controlled trials found that the addition of SGLT2 inhibitors (SGLT2i) to conventional diuretic therapy for...
Treatment of patients with diabetes and CKD: Key takeaways from KDIGO guidelines Dr. Kamal Kant Kohli9 Jan 2023 8:00 PM ISTThe latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers advice for treating patients...
SGLT2 inhibitors lower chronic kidney disease risk in diabetes patients with higher DCSI: Study Medha Baranwal7 Jan 2023 10:00 AM ISTTaiwan: The use of sodium-glucose cotransporter-2 inhibitors (SGLT2Is) significantly lowers the risk of chronic kidney disease (CKD) in type 2...
Use of SGLT2 inhibitors tied to lower dementia risk in older people with type 2 diabetes: Study Medha Baranwal3 Jan 2023 11:45 AM ISTCanada: The new use of sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with dipeptidyl peptidase 4 (DPP-4) inhibitors confers 20% lower...
GLP-1 receptor agonists and SGLT-2 inhibitors reduce COPD exacerbations among diabetes patients Aditi7 Dec 2022 10:45 AM ISTCanada: A recent study published in the BMJ has highlighted that glucagon-like peptide 1 (GLP-1) receptor agonists, and sodium-glucose...
Early initiation of SGLT2 inhibitors reduces MACE in Type 2 Diabetes patients at ASCVD risk Aditi29 Nov 2022 12:15 PM ISTChina: An investigation has revealed that initiation of SGLT2 inhibitor early in Type 2 Diabetes (T2D) patients reduces the rates of major adverse...
